Page 1 of 44

An Analysis on Working Capital Management of Beximco Pharmaceutic...

Continues for 43 more pages »
Read full document

An Analysis on Working Capital Management of Beximco Pharmaceuticals Limited

Page 1 of 44
An Analysis on Working Capital Management of Beximco Pharmaceuticals Limited

Letter of Transmittal

16th April, 2012
To,
Umma Rumana Huq
Lecturer of Finance, School of Business
United International University (UIU)
House # 80, Road # 8A (Old-15)
Dhanmondi, Dhaka 1209

Dear Madam,
Here is the recommendation report on Working Capital Management of “BEXIMCO PHARMACEUTICALS LTD.” that you authorized in your letter on February 29th, 2012. As you read the report, you will get some idea about the pharmaceuticals industry of Bangladesh through our concerned organization. This report contains all the necessary information about the BEXIMCO PHARMACEUTICALS LTD. as like the mission and vision, the brief about all the activities and their services they performed and some other issues as your recommendation. We collected all this necessary information by internet, book and the annual report. We, therefore, pray and hope that you will encourage our work by accepting this report and if you have any further queries about the report you can contact us.

SincerelyAccepted By

Md. Shaidul Hossain| ID-111092201| |
Mujammil Alam Chowdhury| ID-111092080| |
Md.Ibne Arafat Mazumder| ID-111091138| |
Umma Rumana Huq

Executive summary
The history of Pharmaceuticals business of the company dates back to the early 70s, when it started to import market and distribute medicines from world renowned companies like Upjohn inc. of USA and Bayer AG of Germany. Since the very beginning, the company was highly successful in generating increased demand for its products which eventually justified local production. According, a Pharmaceutical manufacturing facility was designed and constructed in 1980 under the technical supervision of Upjohn Inc. of USA, to manufacturing their products under license. Product made under license of Bayer AG of Germany followed. After its initial years of struggle, Beximco Pharma broke ground with the...